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Alzheimer's disease (AD) is a neurodegenerative disorder that results from a loss of synaptic transmission and ultimately cell death. The
presenting pathology of AD includes neuritic plaques composed of beta-amyloid peptide (Aβ) and neurofibrillary tangles composed of
hyperphosphorylated tau, with neuronal loss in specific brain regions. However, the mechanisms that induce neuronal cell loss remain
elusive. Focal adhesion (FA) proteins assemble into intracellular complexes involved in integrin-mediated communication between the
extracellular matrix and the actin cytoskeleton, regulating many cell physiological processes including the cell cycle. Interestingly, recent
studies report that integrins bind to Aβ fibrils, mediating Aβ signal transmission from extracellular sites of Aβ deposits into the cell and
ultimately to the nucleus. In this review, we will discuss the Aβ induced integrin/FA signaling pathways that mediate cell cycle activation
and cell death.
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In tissue, the ECM regulates many aspects of cellular
function. Typically, specific ECM molecules bind to integrin
cell surface receptors and activates downstream focal adhesion
(FA) cell adhesion molecules (CAMs) involved in the regu-
lation of anchorage-dependent cell survival signals [1–6]. Prior
studies indicate that focal adhesion kinase (FAK) plays an
important role in cell cycle progression at the G1/S transition
by regulating the expression and activity of cell cycle proteins
[7]. Integrins and numerous FA CAMs are expressed in all
cells throughout the brain and numerous studies indicate a role
for integrin signaling in neurite outgrowth during differentia-
tion and in response to the toxic effects associated with
neurodegeneration [5,8–12]. Integrins have now been shown to⁎ Corresponding author. Tel.: +1 412 383 7819; fax: +1 412 648 1916.
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mobilization, and/or cooperatively with growth factor signaling
through cell surface growth factor receptors [9,13–15].
Specifically, if fibrillar Aβ is added to cells in culture, both
FAK and paxillin are rapidly phosphorylated leading to
downstream signaling events that can regulate cell viability
[9,13,14]. Neuronal degeneration in AD occurs in specific
regions of the brain and these cell type specificities are most
likely dependent on gene expression of cell cycle regulatory
proteins. Recent data indicate that fully differentiated and
mature neurons in the adult brain exhibit evidence of cell cycle
activation including DNA synthesis upon oxidative stress or
exposure to Aβ fibrils [16–21]. Therefore, we propose that
alterations in the integrin/FAK/FA signaling pathway by
fibrillar Aβ induces cell death within neurons that concurrently
exhibit activation of cell cycle proteins. Neuronal viability and
synaptic loss during the course of AD and potentially other
neurodegenerative disorders may be solely mediated through
FA signaling. Attention to focal adhesion proteins, and
downstream pathways warrant further investigation in AD
and highlight new targets for therapy.
439J. Caltagarone et al. / Biochimica et Biophysica Acta 1772 (2007) 438–4452. Aβ toxicity through integrin signaling
2.1. Integrins
Cells adhere to ECM, basement membrane or connective
tissues, to regulate various cellular processes including growth,
proliferation, survival, differentiation, morphology, migration,
and death [2,5]. The ECM signals through the cell surface
integrins, a family of transmembrane subunits including 18
alpha and 9 beta subunits which generate at least 24 different
integrins that function as heterodimeric receptors [2,4,5].
Integrins mediate both cell/ECM and cell/cell adhesions,
although they do not contain intrinsic enzymatic activities
[2,16,22,23]. Instead, they associate with numerous intracellular
effector CAMs. Activated integrins induce CAM activation by
tyrosine phosphorylation during the initial stages of cell
adhesion [10,11,24,25]. These CAMs assemble into immature
less dense peripherally located FA complexes and mature more
dense centrally located FA complexes associated with actin
stress fibers [25,26]. More than 50 CAMs are localized to FAs
coupling to the actin cytoskeleton and regulating the structural
components of the FAs to efficiently organize multiple signaling
pathways (Fig. 2). Structural CAMs include actin, α-actinin, α-
tubulin, hydrogen peroxide inducible clone 5 (hic-5), paxillin,
Crk associated substrate (p130cas), talin, tensin, vinculin, and
zyxin. Signaling CAMs include FAK, Fyn, phosphoinositide-3
(PI-3) kinase, c-Abl, Crk, Csk, Grb-2, Nck, and PYK2 [5,22,23].
Many of these signaling CAMs are tryrosine kinases known to
be upstream of serine/threonine kinases including members of
the mitogen activated protein kinase (MAPK) pathway, cyclin
dependent kinase 5 (CDK5), and glycogen synthase kinase-3β
(GSK-3β) [2,4,5,8,22,25]. In addition, protein tyrosine phos-
phatases (PTP-1D, PTP-PEST, and PTP-1B) have been shown
to dephosphorylate CAMs upon cell detachment and regulate
FA turnover [2,3,5,22]. CAMs localized to FAs have been
shown to be involved in bidirectional signaling including the
compartmentalization of integrin activated downstream signal-
ing molecules regulating “outside-in-signaling” and the local-
ization and affinity of integrin receptors to regulate “inside-out-
signaling” [1,2,4,5,23]. Ultimately, cell adhesion signaling
through integrins and FAs can impact the viability of the cell.
Integrins are expressed in all cells throughout the brain and
influence long-term potentiation (LTP) in hippocampal neurons,
regulate neurite outgrowth induced by growth factors, and
regulate survival and death signals [5,8–11]. Not surprisingly,
numerous FA CAMs are also expressed in brain and numerous
studies indicate a role for integrin signaling in neurite outgrowth
during differentiation and in response to the toxic effects
associated with neurodegeneration [8,9,12–15]. Neurite out-
growth is promoted by the growth of neuronal cells on laminin,
an integrin substrate [10–12,20]. Specific inhibitors of the Src-
family kinases can block neurite outgrowth [10–12]. When SH-
SY5Y (human), N1E-115 (rat), and Neuro-2a (mouse) cells
were plated on laminin and treated with retinoic acid (RA) to
induce neuronal differentiation, both FAK and paxillin were
shown to have increased tyrosine phosphorylation compared to
adhesion during active neurite outgrowth [10,13,27].2.2. FA unit and its function
FAK is a non-receptor tyrosine kinase responsible for
integrin clustering and signaling [28–30]. When cells adhere
to the ECM, integrins are activated and FAK is autopho-
sphorylated at position Y397, creating a high affinity-binding
site for Src-homology 2 (SH2) domain containing proteins
[3,4,28–30]. Src family kinases (Src and Fyn) contain SH2
domains and recognize phosphorylated FAK-Y397 [3,4,13,28–
30]. This complex can further phosphorylate FAK and other FA
structural and signaling CAMs including paxillin and p130cas
[3,4,28–30]. The assembly of FAK/Src family/paxillin/p130cas
creates the essential four CAMs necessary for FA stabilization
and integrin signaling that has been termed “quartenary
signaling and structural FA-unit” [4,31] (Fig. 1). The FA-unit
connects the various signaling CAMs mobilized to FAs to
coordinate integrin clustering, cell–cell adhesion, and growth
factor signaling [1,2,4,5,22,23,28,30]. In fact, this ECM/
integrin/FA-unit pathway is involved in the regulation of
anchorage-dependent cell survival [1–5]. Disruption of this
pathway, either through the loss of cell adhesion or microin-
jection of anti-FAK antibodies, results in the activation of an
anchorage-dependent cell death pathway called anoikis (Greek
for “homelessness”) [1–5,23,30]. Expression of constitutively
active FAK can prevent anoikis in anchorage independent cells,
including cancer cells [1,3,28–30]. Cell adhesion to the ECM
and over-expression of FAK protects cells from oxidative stress
by H2O2 or ionizing radiation (IR) induced apoptosis [3,4,30].
The anti-apoptotic effect is dependent on FAK Y397-autopho-
sphorylation and the PI3-K/Akt survival pathway [3,4,30].
Recently, FAK has also been shown to directly interact with and
inhibit the tumor suppressor protein p53 induced apoptotic
signaling and induced the expression of cdk inhibitor p21
[32,33]. Interestingly, p53 also has the ability to directly
regulate the expression of FAK and provide a negative feedback
mechanism for p53-induced apoptosis leading towards cell
survival [32]. Therefore, FAK has the ability to regulate
multiple survival pathways involved in cell death or survival.
These findings support the important role for cell attachment in
cell adhesion-mediated drug resistance and resistance to IR.
Such pathways may also contribute to neuronal cell death/
survival pathways during AD.
In addition to regulating cell adhesion and survival path-
ways, FAK and paxillin also function during neuronal
differentiation [10–12]. Nerve growth factor (NGF) increases
the level of paxillin tyrosine phosphorylation during neuro-
nal differentiation in PC-12 cells [12]. Two members of the
FAK family (FAK and PYK2) regulate neurite outgrowth in
both PC-12 and SHSY-5Y cells [34]. The c-Jun N-terminal
kinase (JNK) pathway has also been shown to activate pax-
illin during cell migration in PC-12 cells [35]. Finally,
during NGF induced neuronal differentiation p38 MAPK
and CDK5/p35 were shown to activate paxillin [12]. The
role of FA CAMs in neurite outgrowth and neuronal differ-
entiation is now appreciated and investigators are interested
in how FAs function in neurodegenerative diseases such as
AD.
Fig. 1. Early signaling pathways mobilized at focal adhesion formation. Integrin activation/adhesion promotes FAK autophosphorylation site recruits SH2 domain
proteins including Src and Fyn leading to further FAK phosphorylation and other FA proteins including paxillin. Phosphorylated paxillin then binds to p130CAS
forming the FA unit. Integrin receptor binding to fibrillar Aβ mimics early ECM/integrin signaling.
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Integrins can bind Aβ and activate FAs through integrin
clustering, CAM mobilization, and/or cooperatively with
growth factor signaling through cell surface growth factor
receptors [9,13–15] (Fig. 2). The phosphorylation of tyrosine
residues has been shown to be involved in numerous cell
signaling pathways leading to Aβ toxicity which have
stimulated studies examining how integrins modulate the
toxic effects of Aβ [9,13–15]. Both FAK and paxillin were
found to be tyrosine phosphorylated after exposure to fibrillar
Aβ, well in advance of cell death [9,13–15]. Aβ induced cell
death was found to be dependent on cell anchorage and required
the treated cells to have a neuronal phenotype, actin
cytoskeleton, and Aβ induction of tyrosine phosphorylation
[9,13–15]. In a recent report, when SHSY-5Y cells treated with
fibrillar Aβ, FAK or paxillin phosphorylation status was not
altered until they were differentiated by retinoic acid (RA)
[10,13,27]. RA differentiated SHSY-5Y cells treated with
cytochalasin D to disrupt actin polymerization or monomer
Aβ did not alter tyrosine phosphorylation of FAK or paxillin
nor induce cell death [10]. Fibrillar Aβ exposure did not induce
changes in the overall protein levels of FAK or paxillin but
induces a substantial increase in their tyrosine phosphorylation
(FAK-Y397 and paxillin-Y31/118) and evidence of protein
mobilization from the cytosolic fraction to the membrane
fraction [9,13,14]. Specifically, FA size and numbers that are
positive for paxillin were found to be elevated in fibrillar Aβ
treated neurons [14]. These results were specific to FAK and
paxillin because no changes in the mobilization of another FA
protein, vinculin, were found [14]. It has been suggested that in
cell culture the early effects of fibrillar Aβ are the induction of
FAK and paxillin tyrosine phosphorylation, which mimic earlyevents in integrin signaling during adhesion and/or growth
factor signaling [9]. Therefore, FAK and paxillin are rapidly
phosphorylated by fibrillar Aβ, leading to downstream sig-
naling events that can regulate cell viability.
To investigate the downstream pathways activated by FAK
in primary cortical neurons, Williamson et al. used a variety of
kinase inhibitors and demonstrated that FAK activated by
fibrillar Aβ induces both ERK2 and GSK-3 serine/threonine
kinase signaling pathways [9]. FAK activation relied on both
PI3-K and the Src family member Fyn for downstream
signaling. Interestingly, FAK activation did not rely on ERK1,
Src, PYK2, PKC, or Ca+2 signaling. Fibrillar Aβ causes an
increase in the tyrosine phosphorylation of MAP2c and tau that
could be blocked with inhibitors specific for Src family kinases
and PI3-K. ERK2 activity was sustained for at least 1 h and tau
phosphorylation occurred on serine residues recognized by the
paired-helical-filament-1 (PHF-1) antibody. Thus, it is likely
that FAK/Fyn/PI3-K activation induces ERK2 and GSK-3
signaling and phosphorylation of tau and MAP2c. In this model
system FAK also induced anti-apoptotic signaling via the
sequential activation of Fyn/FAK/PI3-K/MAPK pathways [9].
However, incomplete activation of these pathways fails to
enhance cell survival and may lead to cell death. Fibrillar Aβ
does not activate the complete Fyn/FAK/PI3-K/MAPK path-
ways and therefore the incomplete mimicking of this survival
pathway may contribute to neuronal cell death during AD.
Paxillin is a member of the group III LIM domain family,
closely related to hic-5, localizes in FAs and implicated in AD
pathology [14,15,25] [Caltagarone, J. and Bowser, R., unpub-
lished data]. Paxillin was detected in dystrophic neurites
surrounding amyloid plaques and co-localized to hyperpho-
sphorylated tau in primary neuronal cultures and human ADbrain
[15]. The c-terminal LIM domains of paxillin that are responsible
for many protein–protein interactions are required for Aβ-
Fig. 2. Focal adhesions regulate cell cycle progression. Fibrillar Aβ binds to integrin and activates FA signaling pathway to regulate cell cycle through different
pathways including MAPK, PI3-K, and GSK-3β kinases (see text for details). The FA also receives input by growth factor receptors and cell–cell adhesions
(cadherins). The sum of all inputs determines gene expression for cell survival and/or cell cycle progression through numerous transcriptional regulators. Signaling
inputs from the ECM, growth factor receptors, and cadherins to the FA unit in the cytoplasm regulates cell cycle progression. Transcriptional regulators and nuclear
events are denoted in black boxes.
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While hic-5 and paxillin share many interacting partners, they are
believed to act competitively in many signal transduction
pathways [24]. The potential interactions between hic-5 and
paxillin have not been studied in any neuronal system andwarrant
further investigation. Therefore, hic-5 and paxillin localization
and subsequent interactions could lead to downstream signaling
events that regulate neuronal dystrophy and cell death.
3. Integrin mediated cell cycle activation in AD
3.1. Cell cycle activation in AD
The neuronal degeneration of AD occurs in specific regions
of the brain, including the hippocampus, frontal cortex and
temporal cortex, that function in learning, memory and
language. Mature neurons are arrested in the cell cycle G0
phase to permit the ongoing morphological alteration and
synaptic remodeling. Thus, downregulation of G0 arrest
proteins or induction of G1 entry proteins will result in the
unbalance between cell cycle and differentiation control.
Cell cycle progression is controlled by regulating activity of
a series of CDKs through the coordinated expression of cyclins
and cyclin dependent kinase inhibitors (CDKI) [36]. Cyclin D1
is a critical regulator of the cell cycle transition from G0 to G1
phase. Accumulation of the cyclin D1/cdk4 complex leads to
activation of kinases that phosphorylate and inactivate retino-
blastoma protein (Rb), releasing its inhibition of E2F and
allowing the transcription of E2F-target genes, such as cyclin E,
cyclin A and cdc2. Cyclin E forms a complex with cdc2 andpromotes G1 to S phase transition. Both cyclinE and cdc2 have
been shown to be upregulated in cell culture models of neuronal
cell death [37]. The activity of cyclin D1/cdk4 complex and
cyclin E/cdc2 complex is regulated by CDKI, p27 and p21,
respectively. Increased levels of p27 and phosphorylated p27
(Thr187) are present in the cytoplasm of vulnerable neuronal
populations in AD brain [38]. Phosphorylated p27 (Thr187) co-
localizes with dystrophic neurites, neurofibrillary tangles and
neuropil threads.
In AD, cyclin D and cdk4 show aberrant expression in the
hippocampus and subiculum, but not in the cerebellum [39]. We
have demonstrated increased phosphorylated Rb protein (ppRb)
and E2F1 immunoreactivity in AD brain compared to control
brain, and ppRb was predominantly localized within the nucleus
while E2F1 was in the cytoplasm [40]. Both ppRb and E2F1
were found in the cells surrounding a subset of Aβ -containing
plaques. In vitro cell models exhibit similar ppRb and E2F1
distributions in PC12 cells upon Aβ treatment [18]. Increased
levels of Cyclin D1, cyclin E and ppRb have been demonstrated
in the early stage of AD, however, their levels are decreased by
late stage AD [41].
MAPK is phosphorylated by its upstream kinase called
MAPKK. Both MAPK and MAPKK exhibit increased
expression in potentially vulnerable neurons still unaffected
by neurofibrillary degeneration during the early stages of AD
[42]. The subcellular re-distribution of MAPK from cytoplasm
to nucleus also indicates that MAPK might contribute to AD
pathology via activating downstream nuclear signal pathways
regulating protein transcription and/or translation. It is well
known that MAPK signaling pathway contributes to neuronal
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or indirectly activating downstream kinases that consequently
phosphorylates tau [43]. However, additional evidence in cancer
biology indicates that MAPK signaling pathway plays a role in
the balance between cell survival and death through its influence
on cell cycle progression, as discussed above. Since abnormal
upregulation of cell cycle regulators and MAPK activation have
been found in AD and MAPK signaling pathway is also
activated in AD, it remains to be determined if the MAPK
signaling pathway promotes cell cycle re-entry in AD.
3.2. Integrin/FAK activation of the cell cycle
Prior studies indicate that FAK plays an important role in cell
cycle progression at the G1/S transition by regulating the
expression and activity of cell cycle proteins including cyclins,
cyclin dependent kinases (CDKs) and CDK inhibitors [7]. As
discussed above, activation of FAK leads to autophosphoryla-
tion and binding to intracellular signal molecules including Src
and PI3-kinase [28]. FAK/Src association activates ERK
through two different signal pathways, whose phosphorylation
and activation was associated with neuronal cell bodies and
dystrophic neurites around plaques in late AD [44]. The first
pathway phosphorylates FA proteins paxillin and p130cas, and
leads to activation of MAPK signaling pathway through
recruiting FA adaptor proteins Crk and Nck [45]. P130cas has
been shown to be functional in central neuronal system
disorders, such as hypoxia–ischemia induced neuronal degen-
eration [46]. The other pathway is activated upon binding with
FA adaptor Grb2/SOS and Ras dependent phosphorylation, a
family of small G protein including Ras, Rac and Rho proteins,
linking growth factor signaling and tyrosine kinases with MAP
Kinase, JNK, and p38 MAP kinases [47,48]. After activation of
the ERK signaling pathway by FAK, Cyclin D1 is upregulated
at the transcriptional level [29].
FAK also interacts with PI3-K to activate the PI3-K signaling
pathway, regulating cell survival and cell progression by Akt,
Rac and PKC [7]. A recent study reported that in tumor cell
lines, FAK induced PI3-K/PKC/Akt activation resulted in an
induction of cyclin D3 expression and promotion of cell cycle
progression from G1 to S phase [49]. The induction of cyclin
D3, but not cyclin D1, also has been demonstrated in endothelin
treated astrocytes [50]. However, cyclin D3 induction in
astrocytes is via the small G-protein Rho, and is not dependent
on PI3-K and Src. This difference indicates that FAK regulates
cell cycle progression through different signal pathways in
different cell types. The signal pathways involved in the
function of FAK on cell cycle regulation in neurons remain
unclear. However, FAK activated by amyloid beta peptide 1–42
induced MAPK signaling pathways through its association with
Fyn, instead of Src in primary cultured cortical neurons [9]. As
noted above, Aβ leads to incomplete activation of the FAK/Fyn/
PI3-K/MAP kinase pathways that can induce cell death. In
addition, FAK activation of ERK kinase pathways may
upregulate cyclin D1 and induce cell cycle progression.
However, Guan and his colleagues found that FAK/PI3-K
association is insufficient for cell cycle progression but FAK/Src complex plays an essential role [51]. Additionally, Src-
dependent association of FAK with p130cas and Grb2 are both
required for the cell cycle regulation by FAK. Grb2 regulates the
cell cycle as an adaptor for cytoskeleton proteins. Recently, it
has been reported to bind with c-terminal of amyloid protein
precursor (APP) and this interaction increases in reactive
astrocytes of AD, resulting in Ras/MAPK activation [52,53].
Cyclin D1, a key component of the cell cycle, is regulated by
FAK by multiple pathways [28]. A recent study demonstrated
that FAK upregulates cyclin D1 expression through ERK
activation in fibroblast cell lines [29]. After the Ras/Raf/MEK/
ERK signal pathway is activated by FAK, ERK phosphorylates
its downstream target Ets. Ets then binds to the Ets binding
consensus site B, EtsB, in the promoter of the cyclin D1 gene to
activate its transcription. However, the MEK/ERK pathway not
only acts to induce cyclin D1 gene transcription but functions
post-translationally to enhance cyclin D1 assembly with CDK4
and sequester p27Kip1 from inhibiting the cyclin E/CDK2
complex [54]. In addition, the PI3-K/Akt signal pathway,
another downstream target of FAK, regulates the phosphoryla-
tion and turnover of cyclin D1 [55]. Finally, Rac increases
cyclin D1 protein level through stabilizing cyclin D1 mRNA
[23]. Integrin mediated FAK activation also results in a decrease
of p21 and p27Kip, key CDK inhibitors [28].
In summary, FAK/Src or FAK/Fyn association upregulates
cyclin D1 expression at the transcriptional level through ERK,
PI3-K or Rac signaling pathway and can stabilize cyclin D1
mRNA through Rac. FAK also regulates the turnover of cyclin
D1 through PI3-K/Akt signaling pathway, and modulates the
level of key CDK inhibitors (Fig. 2).
4. Integrin mediated transcription
Cell type specificities in the control of the cell cycle by the
ECM-integrin-FAK-FA pathway are most likely dependent on
gene expression of cell cycle regulatory proteins. As discussed
above, FAK signaling is directly involved in the regulation of
cyclin D1 [28,29]. Activation of these transcription factors is
dependent on the activities of FAK/Src and FAK/PI3-K
complexes and directly targets the promoter of cyclin D1.
However, FAK activation can also regulate the expression of
transcription factors that can indirectly regulate the expression
of cell cycle regulators. Recently FAK was shown to regulate
the expression of a member of the Kruppel-like factor (KLF)
family of transcription factors [56]. The KLF family contains at
least 25 members, many of which are important regulators of
cell cycle regulators and have been shown to both positively and
negatively regulate the cyclin D1 promoter in various cells [56–
58]. In mouse fibroblast cells, KLF8 was shown to positively
regulate cyclin D1 expression and cell cycle progression that is
dependent on both FAK/Src and FAK/PI3-K integrin mediated
signaling pathways [56]. FAK activities were found to coordi-
nate the expression of cyclin D1 promoter element through a
“temporal differential manner” of the cell cycle with an early
induction through Ets binding followed by a later induction
after FAK up-regulated the expression of KLF8. Numerous
types of human cancer have elevated FAK and KLF8 expression
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during tumorigenesis [56–59]. However, other members of the
KLF family including KLF1, 4, 6, and 7 have all been shown to
be negative regulators of cell cycle progression by decreasing
cyclin D1 promoter activity and increasing cdk inhibitor p21
expression levels [57,58]. KLF7 is also believed to control
neuronal differentiation and exit from the cell cycle by
increasing expression of TrkA, a receptor for NGF [57]. How
integrin signaling mediated by FAK regulates the cell cycle
progression dynamically either positively (Ets and KLF8) or
negatively mediated by members of KLF family in neuronal
cells and AD remains to be determined.
The complex balance of both positive and negative signals
for cyclin D1 expression during cell cycle progression at
multiple layers as described for FAK is conserved in other well-
known pathways that utilize FA's. Wnt signaling through
membrane bound frizzled protein family members and β-
catenin mediates cell–cell adhesion signaling to the actin
cytoskeleton similar to how FAK mediates ECM-cell adhesion
signaling [22,60–62]. GSK-3β is an important negative
regulator in β-catenin signaling through phosphorylating and
targeting β-catenin to the proteosome for removal [61]. Not
surprisingly, β-catenin is also an important mediator in the
signaling of cell cycle events [61]. The β-catenin interaction
and regulation of T cell factor (TCF) transcription factor has
been well characterized in development and regeneration in
multiple tissue types [60,61]. Enhanced β-catenin signaling and
activation of TCF has been shown to induce cyclin D, bcl-2, and
engrailed-1/2 (en-1/2) expression [61,63,64]. These proteins
function during development and favor cell survival and cell
cycle progression. In AD, the Wnt/β-catenin/TCF pathway is
disrupted with subsequent loss of β-catenin expression and TCF
survival signaling [61,63,64]. However, activation of the Wnt/
β-catenin/TCF survival pathway by insulin, protein kinase C
(PKC), agonists for PPARγ, and inactivation of GSK-3β all
have the ability to protect primary cortical neurons to Aβ
induced cell death [59,61,63,64]. β-catenin can also mediate
cell cycle arrest through enhanced Forkhead box O (FOXO)
transcriptional activity [62,65,66]. Under conditions of oxida-
tive stress, β-catenin interacts with FOXO for translocation into
the nucleus to induce the expression of cell cycle inhibitor p27,
leading to cell cycle arrest in late G1 phase [62]. Thus, CAMs
associated with at least two distinctly different adhesion
complexes (ECM/integrin and cell/cell) dynamically regulate
the progression and arrest of the cell cycle. The mechanism of
cell adhesion complexes regulating the cell cycle is redundant
yet specific for unique signaling inputs. Determining how focal
adhesion complexes regulate neuronal viability in AD will lead
to novel therapeutic approaches to modulate neuronal survival
and synaptic remodeling during AD.
A number of CAMs have been shown to shuttle between
FA's and the nucleus to regulate gene expression, including c-
Abl, β-cat, CASK, CDK5, ERK, FAK, GSK3β, ILK, JAB1,
PINCH, PYK2, and members of the LIM family of proteins
(hic-5, paxillin, Trip6, leupaxin, and zyxin) [22,25]. Many of
which have been implicated in the molecular pathology of
neurodegenerative diseases, though continued investigationsare required to determine the functional role for each of these
proteins in neurodegeneration.
Our lab and others have shown that Kelch-like Ech
Associated Protein (Keap1) is an actin binding protein that
has the ability to regulate the subcellular distribution of
transcription factors including Fetal ALZ-50 Reactive Clone 1
(FAC1) and Nrf2 in neurons [67–70]. In normal conditions,
Keap1 is localized to periphery FAs containing paxillin,
vinculin, and tyrosine phosphorylated proteins [68]. Keap1
bound to Nrf2 targets their destruction by ubiquitin-mediated
pathways [69,70]. However, under conditions of oxidative
stress both Keap1 and Nrf2 translocate to the nucleus and
nuclear Nrf2 positively regulates promoters containing the anti-
oxidant response elements (AREs) [68–70]. The induction of
Nrf2 mediated survival pathways at the transcription level is
considered a conserved function in every cell type [70]. FAC1 is
a developmentally regulated transcription factor that modulates
expression of numerous genes [18,71]. In AD brain and PC-12
cells treated with Aβ, FAC1 exhibits altered expression and
subcellular distribution from the cytoplasm to the perinuclear
region in cells [18]. FAC1 is believed to be an important
regulator in Rb and E2F cell cycle activities in response to
neurotoxic signals [71]. Recently, FAC1 was shown to be an
alternative splice form from a much larger bromodomain PHD
transcription factor (BPTF) that is implicated in chromatin
remodeling [72]. En-1 gene expression was positively regulated
by BPTF [72]. Since en-1 and en-2 gene expression is required
for normal neuronal development, altered expression and
subcellular distribution of factors that associate with their
promoter elements could disrupt engrailed expression and
activities in AD. How integrin signaling regulates the FA/
Keap1/Nrf2/ARE survival pathway and FA/Keap1/FAC1/BPTF
transcriptional activities in response to toxic neuronal stimuli
remains to be determined but supports the role of altered
distribution of CAMs in regulating numerous cellular responses
to toxic stimuli (Fig. 2).
5. Integrins modulate neuronal survival
During early steps of the cell cycle, the ECM/integrin/FAK/
FA pathway regulates anchorage-dependent cell survival [2,5].
Disruption of this cell attachment pathway results in a specific
cell death called anoikis and this ECM/integrin/FAK/FA
pathway may actually limit neuronal mitosis [1,3]. Fully dif-
ferentiated and mature neurons in the adult brain exhibit
evidence of cell cycle activation upon oxidative stress or ex-
posure to Aβ fibrils [16–20]. A recent study used a genomic
probe for chromosome 11 to identify a pyramidal neuron in the
hippocampus of AD brain with four copies of chromosome 11
indicating that this neuron synthesized DNA [19,21].
In vitro models of neuronal injury using Aβ and oxidative
stress have reproduced the induction of integrin signaling, cell
cycle regulators, DNA damage, and apoptosis. Recent models
of S-phase induction in neurons include two mouse mutants
(stagger and lurcher), overexpression of viral oncogenes and
E2F1, targeted disruption of Rb, and a model of stroke show
increased levels of BrdU incorporation in neuronal cells
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incorporation is not specific to DNA replication and may also
be incorporated during DNA repair [19]. Post-mitotic cells have
increased vulnerability to DNA damage and repair [19]. Growth
factor and ECM/integrin signaling appear to inhibit DNA
synthesis in neuronal but not in other cell types including glia
[20]. We propose that activation of the integrin/FAK/FA
pathway by fibrillar Aβ induces cell death within neurons
that concurrently exhibit activation of cell cycle proteins. Loss
of ECM/integrin signaling (i.e. loss of cell attachment sig-
naling) may induce anoikis mediated cell death with concurrent
dis-inhibition of DNA synthesis. Therefore, the appearance of
DNA synthesis in some neurons during AD may result from
altered focal adhesion signaling.
6. Conclusion
Activation of FAK/paxillin by Aβ can induce tau phosphory-
lation, cell cycle activation, and the loss of cell adhesions can
lead to subsequent cell death. The alteration of expression and
function of FAK signaling pathway related proteins in AD
brains supports our hypothesis that integrin/FAK signal
pathway induces neuronal cell cycle re-entry and neuronal
cell death. Given the data relating focal adhesion activation by
Aβ and neuronal cell death pathways, attention to focal
adhesion proteins, and downstream pathways warrant further
investigation in AD and highlight new targets for therapy.
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